Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase

The Dex-CSDH trial is a randomised, double-blind, placebo-controlled trial of dexamethasone for patients with a symptomatic chronic subdural haematoma. The trial commenced with an internal pilot, whose primary objective was to assess the feasibility of multi-centre recruitment. Primary outcome data...

Descripción completa

Detalles Bibliográficos
Autores principales: Edlmann, Ellie, Thelin, Eric P., Caldwell, Karen, Turner, Carole, Whitfield, Peter, Bulters, Diederik, Holton, Patrick, Suttner, Nigel, Owusu-Agyemang, Kevin, Al-Tamimi, Yahia Z., Gatt, Daniel, Thomson, Simon, Anderson, Ian A., Richards, Oliver, Gherle, Monica, Toman, Emma, Nandi, Dipankar, Kane, Phillip, Pantaleo, Beatrice, Davis-Wilkie, Carol, Tarantino, Silvia, Barton, Garry, Marcus, Hani J., Chari, Aswin, Belli, Antonio, Bond, Simon, Gafoor, Rafael, Dawson, Sarah, Whitehead, Lynne, Brennan, Paul, Wilkinson, Ian, Kolias, Angelos G, Hutchinson, Peter J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458174/
https://www.ncbi.nlm.nih.gov/pubmed/30971773
http://dx.doi.org/10.1038/s41598-019-42087-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458174/
https://www.ncbi.nlm.nih.gov/pubmed/30971773
http://dx.doi.org/10.1038/s41598-019-42087-z

Ejemplares similares